Cmbio
Nynne Nielsen possesses significant experience in the field of microbiome science, currently serving as the Director of Project Portfolio Management at Clinical Microbiomics since August 2017. Nynne has also held roles as a Microbiome Scientist and Project Manager within the same company, as well as serving as a Student Assistant. In 2017, Nynne participated in a summer school program at the University of Cambridge focused on synthetic biology. Nynne's academic background includes a Master's degree in Molecular Biomedicine and a Bachelor of Science in Molecular Biomedicine, both from Københavns Universitet - University of Copenhagen, with additional experience through an exchange program in Biomedicine at the University of Toronto.
This person is not in any teams
Cmbio
Cmbio®, is at the forefront of the human, animal, and planetary health—microbiome science. Formed from the unification of industry leaders like Clinical Microbiomics, CosmosID, MS-Omics, DNASense and Microba’s Research Services, Cmbio® stands as the first global microbiome service and technology company equipped with state-of-the-art multi-omics laboratories and advanced bioinformatics. Our mission is to demystify the complex interplay of the microbiome and its vast influence on health and disease. By integrating applied AI with integrative systems biology, Cmbio® offers unparalleled insights and enterprise solutions that accelerate the pace of discovery and innovation in microbiome research. With GxP-compliant facilities and a robust, scalable software platform, Cmbio® is uniquely positioned to standardize microbiome analysis, ensuring reliability and comparability across global studies. We are committed to advancing scientific understanding and enhancing well-being across all life on our planet. Connect with Cmbio®: Explore how we're making strides in microbiome research and offering cutting-edge solutions to meet the grand challenges of health and sustainability.